Keep an eye on Altimmune Inc. (ALT). The stock is pushing higher thanks to more positive data on its COVID candidate. The company just published positive pre-clinical data for its new single-dose, intranasal COVID-19 vaccine candidate AdCOVID, adding the candidate “stimulates three key immune components: serum neutralizing antibody, T cell responses, and mucosal immunity in the respiratory...
Continue reading >>...
Continue reading >>Wall Street was down for the fourth time in five sessions as heavy losses in Tech stocks highlighted Friday’s action despite mostly positive earnings results. Investors choose to sell-the-news while concentrating on the growing numbers of coronavirus cases and potential shutdowns along with the upcoming Presidential election.The major indexes closed well off the session lows with the final hour...
Continue reading >>...
Continue reading >>Wall Street showed opening gains to start the week but experienced late day selling pressure following heightened rhetoric over a coronavirus stimulus package. With a 48-hour deadline set by House Speaker Nancy Pelosi over the weekend that expires Tuesday, President Trump hit back by saying she doesn’t want to get a deal done before the election.The major indexes closed near the session lows...
Continue reading >>Keep an eye on Altimmune Inc. (ALT). The stock is pushing higher thanks to more positive data on its COVID candidate. The company just published positive pre-clinical data for its new single-dose, intranasal COVID-19 vaccine candidate AdCOVID, adding the candidate “stimulates three key immune components: serum neutralizing antibody, T cell responses, and mucosal immunity in the respiratory...
Continue reading >>